180 related articles for article (PubMed ID: 21109025)
1. Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
Piccini JP; Al-Khatib SM; Hellkamp AS; Anstrom KJ; Poole JE; Mark DB; Lee KL; Bardy GH
Heart Rhythm; 2011 Mar; 8(3):393-400. PubMed ID: 21109025
[TBL] [Abstract][Full Text] [Related]
2. Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).
Fishbein DP; Hellkamp AS; Mark DB; Walsh MN; Poole JE; Anderson J; Johnson G; Lee KL; Bardy GH;
J Am Coll Cardiol; 2014 Jun; 63(23):2560-2568. PubMed ID: 24727258
[TBL] [Abstract][Full Text] [Related]
3. Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials.
Hess PL; Laird A; Edwards R; Bardy GH; Bigger JT; Buxton AE; Moss AJ; Lee KL; Hall WJ; Steinman R; Dorian P; Hallstrom A; Cappato R; Kadish AH; Kudenchuk PJ; Mark DB; Al-Khatib SM; Piccini JP; Inoue LY; Sanders GD
Heart Rhythm; 2013 Jun; 10(6):828-35. PubMed ID: 23416381
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT.
Poole JE; Olshansky B; Mark DB; Anderson J; Johnson G; Hellkamp AS; Davidson-Ray L; Fishbein DP; Boineau RE; Anstrom KJ; Reinhall PG; Packer DL; Lee KL; Bardy GH;
J Am Coll Cardiol; 2020 Jul; 76(4):405-415. PubMed ID: 32703511
[TBL] [Abstract][Full Text] [Related]
5. Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.
Packer DL; Prutkin JM; Hellkamp AS; Mitchell LB; Bernstein RC; Wood F; Boehmer JP; Carlson MD; Frantz RP; McNulty SE; Rogers JG; Anderson J; Johnson GW; Walsh MN; Poole JE; Mark DB; Lee KL; Bardy GH
Circulation; 2009 Dec; 120(22):2170-6. PubMed ID: 19917887
[TBL] [Abstract][Full Text] [Related]
6. Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction: Secondary Analysis of the Sudden Cardiac Death in Heart Failure Trial.
Adabag S; Patton KK; Buxton AE; Rector TS; Ensrud KE; Vakil K; Levy WC; Poole JE
JAMA Cardiol; 2017 Jul; 2(7):767-774. PubMed ID: 28724134
[TBL] [Abstract][Full Text] [Related]
7. Outcomes for patients with anterior myocardial infarction and prior cardiac arrest in the home automated external defibrillator trial (HAT).
Starks MA; Jackson LR; Hellkamp A; Al-Khatib SM; Mark DB; Thomas KL; Nichol G; Lee KL; Davidson-Ray L; Poole J; Anderson J; Johnson G; Bardy GH
Resuscitation; 2021 Nov; 168():75-83. PubMed ID: 34500022
[TBL] [Abstract][Full Text] [Related]
8. Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).
Chen J; Johnson G; Hellkamp AS; Anderson J; Mark DB; Lee KL; Bardy GH; Poole JE
J Am Coll Cardiol; 2013 May; 61(21):2161-8. PubMed ID: 23541974
[TBL] [Abstract][Full Text] [Related]
9. ECG quantification of myocardial scar and risk stratification in MADIT-II.
Loring Z; Zareba W; McNitt S; Strauss DG; Wagner GS; Daubert JP
Ann Noninvasive Electrocardiol; 2013 Sep; 18(5):427-35. PubMed ID: 24047486
[TBL] [Abstract][Full Text] [Related]
10. Early echocardiographic deformation analysis for the prediction of sudden cardiac death and life-threatening arrhythmias after myocardial infarction.
Ersbøll M; Valeur N; Andersen MJ; Mogensen UM; Vinther M; Svendsen JH; Møller JE; Kisslo J; Velazquez EJ; Hassager C; Søgaard P; Køber L
JACC Cardiovasc Imaging; 2013 Aug; 6(8):851-60. PubMed ID: 23850252
[TBL] [Abstract][Full Text] [Related]
11. SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death.
Au-Yeung WT; Reinhall PG; Poole JE; Anderson J; Johnson G; Fletcher RD; Moore HJ; Mark DB; Lee KL; Bardy GH
Heart Rhythm; 2015 Oct; 12(10):2058-66. PubMed ID: 26096609
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
[TBL] [Abstract][Full Text] [Related]
13. Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk Estimates.
Levy WC; Hellkamp AS; Mark DB; Poole JE; Shadman R; Dardas TF; Anderson J; Johnson G; Fishbein DP; Lee KL; Linker DT; Bardy GH
JACC Clin Electrophysiol; 2018 Aug; 4(8):1089-1102. PubMed ID: 30139491
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients.
Jukema JW; Timal RJ; Rotmans JI; Hensen LCR; Buiten MS; de Bie MK; Putter H; Zwinderman AH; van Erven L; Krol-van Straaten MJ; Hommes N; Gabreëls B; van Dorp W; van Dam B; Herzog CA; Schalij MJ; Rabelink TJ;
Circulation; 2019 Jun; 139(23):2628-2638. PubMed ID: 30882234
[TBL] [Abstract][Full Text] [Related]
15. Clinical practice of defibrillator implantation after myocardial infarction: impact of implant time: results from the PreSCD II registry.
Völler H; Kamke W; Klein HU; Block M; Reibis R; Treusch S; Contzen K; Wegscheider K;
Europace; 2011 Apr; 13(4):499-508. PubMed ID: 21123220
[TBL] [Abstract][Full Text] [Related]
16. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
[TBL] [Abstract][Full Text] [Related]
17. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
[TBL] [Abstract][Full Text] [Related]
18. Risk Models for Prediction of Implantable Cardioverter-Defibrillator Benefit: Insights From the DANISH Trial.
Kristensen SL; Levy WC; Shadman R; Nielsen JC; Haarbo J; Videbæk L; Bruun NE; Eiskjær H; Wiggers H; Brandes A; Thøgersen AM; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Signorovitch J; Køber L; Thune JJ
JACC Heart Fail; 2019 Aug; 7(8):717-724. PubMed ID: 31302052
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Elapsed Time from Myocardial Infarction on Mortality and Major Adverse Cardiac and Cerebrovascular Events in ICD Patients.
Bons LR; Dabiri-Abkenari L; VAN Domburg RT; Szili-Torok T; Zijlstra F; Theuns DA
Pacing Clin Electrophysiol; 2015 Dec; 38(12):1448-55. PubMed ID: 26289034
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]